A pharmaceutical company has accepted a project that is expected to increase revenues by $200,000 a year and cash expenses by $15,000 a year. The project will require the purchase of some new equipment that will increase depreciation expenses by $25,000 a year. Net working capital is also expected to increase by $4,000 annually. The firm is in the 215 MARGINAL TAX BRACKET. WHAT IS THE CHANGE IN OPERATING CASH FLOWS?
1. $30,250
2. $18,300
3. $40,750
4. $39,500
5. $44,750